Work

Interim Results of Secondary Endpoints From a Randomized Trial of Cladribine with Early Vs Delayed Rituximab for Treatment of Early Hairy Cell Leukemia

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.2856.2856

Authors: Robert J Kreitman, Wyndham H. Wilson, Hong Zhou, Mark Raffeld, Maryalice Stetler-Stevenson, Evgeny Arons

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2534926696

FWCI:

Cites:

Cited by:

Related to: 10